ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,098, issued on Aug. 25, was assigned to CHILDREN'S NATIONAL MEDICAL CENTER (Washington).

"Genetic diagnostic tool for facioscapulohumeral muscular dystrophy (FSHD)" was invented by Yi-Wen Chen (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions and methods for the diagnosis of Facioscapulohumeral muscular dystrophy (FSHD) using nanopore sequencing and CRISPR/Cas9 enrichment of D4Z4 containing sequences to determine the number of repeats in a D4Z repeat region and methylation of the nucleotide bases in this region."

The patent was filed on May 28, 2021, under Application No. 18/000,256.

*For further information, in...